JPMorgan maintains Overweight on Neurocrine Bio. (NASDAQ: NBIX).Analyst Anupam Rama defends the name saying the recent weakness ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE